إعلان
إعلان

SGRY

SGRY logo

Surgery Partners, Inc. Common Stock

15.72
USD
برعاية
+0.08
+0.49%
٠٨ يناير, ١٦:٠٠ UTC -5
مغلق
exchange

بعد الإغلاق

15.72

+0.01
+0.05%

تقارير أرباح SGRY

النسبة الإيجابية المفاجئة

SGRY تفوق 18 من 40 آخر التقديرات.

45%

التقرير التالي

بيانات التقرير القادم
٠٢ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$883.74M
/
$0.32
التغير الضمني من Q3 25 (Revenue/ EPS)
+7.58%
/
+146.15%
التغير الضمني من Q4 24 (Revenue/ EPS)
+2.24%
/
-27.27%

Surgery Partners, Inc. Common Stock earnings per share and revenue

On ١٠ نوفمبر ٢٠٢٥, SGRY reported earnings of 0.13 USD per share (EPS) for Q3 25, missing the estimate of 0.16 USD, resulting in a -23.03% surprise. Revenue reached 821.50 مليون, compared to an expected 837.45 مليون, with a -1.90% difference. The market reacted with a -25.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 14 المحللين forecast an EPS of 0.32 USD, with revenue projected to reach 883.74 مليون USD, implying an زيادة of 146.15% EPS, and زيادة of 7.58% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Surgery Partners, Inc. Common Stock reported EPS of $0.13, missing estimates by -23.03%, and revenue of $821.50M, -1.9% below expectations.
The stock price moved down -25.42%, changed from $21.50 before the earnings release to $16.04 the day after.
The next earning report is scheduled for ٠٢ مارس ٢٠٢٦.
Based on 14 المحللين, Surgery Partners, Inc. Common Stock is expected to report EPS of $0.32 and revenue of $883.74M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان